POLA-R-CHP in the First-line Treatment of Transformed DLBCL

Clinical trial NCT06743945 · RECRUITING

Trial details

NCT number: NCT06743945
Sponsor: Fudan University
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Transformed Lymphoma

Start date: 2025-02-17
Primary completion: 2027-12-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.